BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 32266790)

  • 1. The potential of probiotics for treating acne vulgaris: A review of literature on acne and microbiota.
    Goodarzi A; Mozafarpoor S; Bodaghabadi M; Mohamadi M
    Dermatol Ther; 2020 May; 33(3):e13279. PubMed ID: 32266790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris.
    Wang Y; Kuo S; Shu M; Yu J; Huang S; Dai A; Two A; Gallo RL; Huang CM
    Appl Microbiol Biotechnol; 2014 Jan; 98(1):411-24. PubMed ID: 24265031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach on the potential use of probiotics in the treatment of skin conditions: acne and atopic dermatitis.
    Mottin VHM; Suyenaga ES
    Int J Dermatol; 2018 Dec; 57(12):1425-1432. PubMed ID: 29676446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of N-acetylcysteine for treatment of acne vulgaris and acne-related associations and consequences: Focus on clinical studies.
    Mardani N; Mozafarpoor S; Goodarzi A; Nikkhah F
    Dermatol Ther; 2021 May; 34(3):e14915. PubMed ID: 33629414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Precision Microbiome Approach Using Sucrose for Selective Augmentation of Staphylococcus epidermidis Fermentation against Propionibacterium acnes.
    Wang Y; Kao MS; Yu J; Huang S; Marito S; Gallo RL; Huang CM
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.
    Han R; Blencke HM; Cheng H; Li C
    Peptides; 2018 Jan; 99():36-43. PubMed ID: 29108811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The increasing importance of the gut microbiome in acne vulgaris.
    Siddiqui R; Makhlouf Z; Khan NA
    Folia Microbiol (Praha); 2022 Dec; 67(6):825-835. PubMed ID: 35711021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of the antimicrobial peptide BLP-7 against Propionibacterium acnes and its anti-inflammatory effect on acne vulgaris.
    Wu Y; Qiang Y; Cao K; Zhang W; Zhang G
    Toxicon; 2020 Sep; 184():109-115. PubMed ID: 32540219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEG-8 Laurate Fermentation of
    Marito S; Keshari S; Huang CM
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Skin Microbiome: A New Actor in Inflammatory Acne.
    Dréno B; Dagnelie MA; Khammari A; Corvec S
    Am J Clin Dermatol; 2020 Sep; 21(Suppl 1):18-24. PubMed ID: 32910436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between quinolone use and resistance of Staphylococcus epidermidis in patients with acne vulgaris.
    Nakase K; Yoshida A; Saita H; Hayashi N; Nishijima S; Nakaminami H; Noguchi N
    J Dermatol; 2019 Sep; 46(9):782-786. PubMed ID: 31254314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in understanding
    Platsidaki E; Dessinioti C
    F1000Res; 2018; 7():. PubMed ID: 30613388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.
    Oh S; Kim SH; Ko Y; Sim JH; Kim KS; Lee SH; Park S; Kim YJ
    Food Chem Toxicol; 2006 Apr; 44(4):552-9. PubMed ID: 16226831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S; Kurokawa I; Katoh N; Watanabe K
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
    Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
    Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propionibacterium acnes and antimicrobial resistance in acne.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris.
    O'Neill AM; Gallo RL
    Microbiome; 2018 Oct; 6(1):177. PubMed ID: 30285861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acne, Microbiome, and Probiotics: The Gut-Skin Axis.
    Sánchez-Pellicer P; Navarro-Moratalla L; Núñez-Delegido E; Ruzafa-Costas B; Agüera-Santos J; Navarro-López V
    Microorganisms; 2022 Jun; 10(7):. PubMed ID: 35889022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review.
    Patel M; Bowe WP; Heughebaert C; Shalita AR
    J Drugs Dermatol; 2010 Jun; 9(6):655-64. PubMed ID: 20645527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acne, the Skin Microbiome, and Antibiotic Treatment.
    Xu H; Li H
    Am J Clin Dermatol; 2019 Jun; 20(3):335-344. PubMed ID: 30632097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.